Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2003-08-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.290.7.932PMID 12928471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited.

  2009cited by this paper
• Inflammation and Atherosclerosis

  2004cited by this paper
• The World Health report 2002.

  2003cited by this paper
• C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

  2003cited by this paper
• Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.

  2003cited by this paper
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study

  2003cited by this paper
• C-reactive protein in the prediction of cardiovascular events.

  2003cited by this paper
• Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

  2003cited by this paper
• Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction.

  2002cited by this paper
• The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke

  2002cited by this paper
• Homocysteine Determinants and the Evidence to What Extent Homocysteine Determines the Risk of Coronary Heart Disease

  2002influential reference
• Homocysteine and cardiovascular disease: current evidence and future prospects.

  2002cited by this paper
• AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

  2002cited by this paper
• Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?

  2002cited by this paper
• Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events*

  2002influential reference
• Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.

  2002cited by this paper
• Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies.

  2002cited by this paper
• Bezafibrate in men with lower extremity arterial disease: randomised controlled trial

  2002cited by this paper
• The search for new risk factors for coronary heart disease: occupational therapy for epidemiologists?

  2002cited by this paper
• C-reactive protein--to screen or not to screen?

  2002cited by this paper
• Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial.

  2002cited by this paper
• Homocysteine, MTHFR 677C→T polymorphism, and risk of ischemic stroke: Results of a meta-analysis

  2002cited by this paper
• C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.

  2002cited by this paper
• Need to test the arterial inflammation hypothesis.

  2002influential reference
• Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

  2002cited by this paper
• MTHFR 677C-->T polymorphism and risk of coronary heart disease: a meta-analysis.

  2002cited by this paper
• Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

  2002cited by this paper
• The World Health Report 2000

  2002cited by this paper
• Inflammation and Stroke: The Leiden 85-Plus Study

  2002cited by this paper
• C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

  2002cited by this paper
• C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study.

  2002cited by this paper
• Inflammation and Atherosclerosis

  2002cited by this paper
• Endothelin Antagonism and Interleukin-6 Inhibition Attenuate the Proatherogenic Effects of C-Reactive Protein

  2002cited by this paper
• Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging).

  2002cited by this paper
• Lowering plasma homocysteine with folic acid in cardiovascular disease: what will the trials tell us?

  2002influential reference
• Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies.

  2002cited by this paper
• Coronary in-stent restenosis: current status and future strategies.

  2002cited by this paper
• Elevated Fibrinogen and Homocysteine Levels Enhance the Risk of Mortality in Patients From a High-Risk Preventive Cardiology Clinic

  2002influential reference
• Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals

  2002cited by this paper
• Power Shortage: Clinical Trials Testing the Homocysteine Hypothesis against a Background of Folic AcidFortified Cereal Grain Flour

  2001cited by this paper
• Incremental Prognostic Value of Elevated Baseline C-Reactive Protein Among Established Markers of Risk in Percutaneous Coronary Intervention

  2001cited by this paper
• Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

  2001cited by this paper
• High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.

  2001cited by this paper
• Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.

  2001cited by this paper
• A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study.

  2001cited by this paper
• Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

  2001cited by this paper
• Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.

  2001cited by this paper
• Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantation.

  2001cited by this paper
• Is coronary risk an accurate surrogate for cardiovascular risk for treatment decisions in mild hypertension? A population validation

  2001cited by this paper
• C-Reactive Protein–Mediated Low Density Lipoprotein Uptake by Macrophages: Implications for Atherosclerosis

  2001cited by this paper
• C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

  2001cited by this paper
• The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.

  2001cited by this paper
• Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

  2001cited by this paper
• Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

  2001cited by this paper
• The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth.

  2001cited by this paper
• Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design

  2001cited by this paper
• Prognostic Influence of Increased C-Reactive Protein and Fibrinogen Levels in Ischemic Stroke

  2001cited by this paper
• Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways.

  2001cited by this paper
• Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation.

  2001cited by this paper
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial.

  2000cited by this paper
• Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a).

  2000cited by this paper
• Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women.

  2000cited by this paper
• Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells

  2000cited by this paper
• C-reactive protein, inflammation and atherosclerosis: do we really understand it yet?

  2000cited by this paper
• A pilot study with simvastatin and folic acid/vitamin B12 in preparation for the Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH).

  2000cited by this paper
• Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis.

  2000cited by this paper
• Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

  2000cited by this paper
• Lipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies

  2000cited by this paper
• A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia.

  2000cited by this paper
• Homocysteine: to screen and treat or to wait and see?

  2000cited by this paper
• Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual?

  2000cited by this paper
• Lipoprotein (a) and stroke

  2000cited by this paper
• Vascular complications of severe hyperhomocysteinemia in patients with homocystinuria due to cystathionine beta-synthase deficiency: effects of homocysteine-lowering therapy.

  2000cited by this paper
• The New England Journal

  2000cited by this paper
• Predictive value of C-reactive protein and troponin T in patients with unstable angina: A comparative analysis

  2000cited by this paper
• C-Reactive Protein in the Arterial Intima: Role of C-Reactive Protein Receptor–Dependent Monocyte Recruitment in Atherogenesis

  2000cited by this paper
• Lipoprotein(a): from ancestral benefit to modern pathogen?

  2000cited by this paper
• Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.

  1999cited by this paper
• The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment.

  1999cited by this paper
• C-reactive protein and outcome after ischemic stroke.

  1999cited by this paper
• Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.

  1999cited by this paper
• Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women.

  1999cited by this paper
• C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction.

  1999cited by this paper
• Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events.

  1999cited by this paper
• Atherosclerosis--an inflammatory disease.

  1999cited by this paper
• Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update.

  1999cited by this paper
• Adjusting therapy to cardiovascular risk status.

  1999cited by this paper
• Fibrinogen, Factor VII and PAI-1 Genotypes and the Risk of Coronary and Peripheral Atherosclerosis: Edinburgh Artery Study

  1999cited by this paper
• Fibrinogen.

  1999cited by this paper
• Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability.

  1999cited by this paper
• Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

  1998cited by this paper
• Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

  1998cited by this paper
• Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

  1998cited by this paper
• Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

  1998cited by this paper
• BCR/IFCC reference material for plasma proteins (CRM 470). Community Bureau of Reference. International Federation of Clinical Chemistry.

  1998cited by this paper
• Prediction of coronary heart disease using risk factor categories.

  1998cited by this paper
• Standardization and Clinical Management of Lipoprotein(a) Measurements

  1998cited by this paper
• C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries.

  1998cited by this paper
• Mortality by cause for eight regions of the world: Global Burden of Disease Study

  1997cited by this paper

• Unveiling the promising pharmacological and molecular insights into Ruppia maritima: Natural source of antidepressant, sedative, and antidiarrheal agents

  2026cites this paper
• Investigating the Secondary Metabolite Profile and Neuropharmacological Activities of Ipomoea purpurea: A Multi‐Method Approach Using GC–MS, In Vivo, and In Silico Techniques

  2025cites this paper
• Cross-sectional study of lipoprotein(a) and the severity of coronary artery disease, cerebrovascular disease, and peripheral vascular disease in a group of South Asian patients

  2025cites this paper
• Homocysteine leads to aortic stiffening in a rabbit model of atherosclerosis.

  2025cites this paper
• Exploring the interplay between myeloproliferative disorders and atherosclerosis

  2025cites this paper
• Overdose Toxicological Effect of Methanol Extract of Popular Edible Colocasia esculenta Linn. Flowers: Biochemical, Hematological, and Behavioral Study on Swiss Albino Mice

  2025influential citation
• Adherence to the Mediterranean Diet and Carotid Intima-Media Thickness in University Students: A Cross-Sectional Study

  2025cites this paper
• Predictive value of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) for all-cause and cardiovascular mortality with non-hyperhomocysteinemia: evidence from NHANES 1999 to 2006

  2025cites this paper
• Determinants of Progression and Regression of Subclinical Atherosclerosis: A Temporal Perspective.

  2025cites this paper
• Concurrent acute myocardial infarction and acute ischemic stroke in a diabetic patient undergoing chemotherapy for non-Hodgkin lymphoma: Should I administer thrombolytic therapy? A case report

  2024cites this paper
• A meta-analysis of the association between high-sensitivity c-reactive protein level and glaucoma

  2024cites this paper
• The Role of Pan-Immune-Inflammation Value in Determining the Severity of Coronary Artery Disease in NSTEMI Patients

  2024influential citation
• Hippocampal atrophy and white matter lesions as predictors of the transition from VMCI to vascular dementia: Implications for early intervention.

  2024cites this paper
• Single‑nucleotide polymorphisms in the promoter of the gene encoding for C‑reactive protein associated with acute coronary syndrome

  2024cites this paper
• Photodynamic Therapy for Atherosclerosis

  2024cites this paper
• Enhancing cardiovascular patients’ knowledge of air pollution: a pilot study evaluating the impact of an educational intervention in cardiac rehabilitation

  2024cites this paper
• Helicobacter pylori infection and rheumatoid arthritis as risk enhancers' factors for atherosclerotic cardiovascular diseases

  2023cites this paper
• The Relationship Between Admission Insulin Resistance Index (AIRI) and In-Hospital Outcome in Non-Diabetic Acute Coronary Syndrome

  2023cites this paper
• Heart Status Regarding Opium and Psychotropics Use in Corpses Referred to Birjand Legal Medicine Center from 2011 to 2018

  2023influential citation
• Computational clustering reveals differentiated coronary artery calcium progression at prevalent levels of pulse wave velocity by classifying high-risk patients

  2023cites this paper
• Genetics and Ischemic Heart Disease: Should We Opt for Genetic Testing for Primary Prevention?

  2023cites this paper
• Coronary artery calcification in endurance athletes: a narrative review Calcificação na artéria coronária em atletas de endurance: uma revisão narrativa

  2022cites this paper
• Clinical significance of early venous enhancement on CT angiography of the ischemic lower limbs

  2022cites this paper
• Orofacial Features and Their Correlation in Cardiovascular Diseases

  2022cites this paper
• Dyslipidemia Diagnosis and Treatment: Risk Stratification in Children and Adolescents

  2022cites this paper
• Synergistic Effects of Inflammation and Atherogenic Dyslipidemia on Subclinical Carotid Atherosclerosis Assessed by Ultrasound in Patients with Familial Hypercholesterolemia and Their Family Members

  2022cites this paper
• Prevalence and Predictors of Insufficient Plasma Vitamin C in a Subtropical Region and Its Associations with Risk Factors of Cardiovascular Diseases: A Retrospective Cross-Sectional Study

  2022cites this paper
• Cardiovascular Disease Risk Factors in HIV-Infected Adults in Nyeri County, Kenya

  2021cites this paper
• ASSESSMENT OF SERUM LIPID PROFILE AND ITS ASSOCIATION WITH CHRONIC PERIODONTITIS- A CLINICO-BIOCHEMICAL STUDY

  2021cites this paper
• Association of human platelet alloantigens encoding gene polymorphisms with the risk of Coronary artery disease in Iranian patients

  2021cites this paper
• Impact of supervised beego, a traditional Chinese water-only fasting, on thrombosis and haemostasis

  2021cites this paper
• The effect of eight weeks of aerobic training and two weeks of detraining on resistin and fibrinogen of elderly male

  2021cites this paper
• 13 (2) January 2021 CVJ.pmd

  2021cites this paper
• Biomarkers and Heart Rate Variability in the Prognosis of Cardiovascular Disease: A Perspective

  2021cites this paper
• Glycans and Cardiovascular Diseases

  2021cites this paper
• Tobacco use and nicotine dependence among patients with diabetes and hypertension in Ballabgarh, India.

  2021cites this paper
• Assessment of the Pharmacological Activities of Ardisia solanacea Roxb: An Ethnomedicinal Plant used in Bangladesh -

  2020influential citation
• Supervised beego, a traditional Chinese water-only fasting, ends up with reduced thrombosis risk without compromising hemostasis capacity

  2020cites this paper
• Roles and Mechanisms of Hawthorn and Its Extracts on Atherosclerosis: A Review

  2020cites this paper
• Bioinformatics Analysis Reveals Diagnostic Markers and Vital Pathways Involved in Acute Coronary Syndrome

  2020cites this paper
• The effect of bay leaf extract Syzygium polyanthum (Wight) Walp. on C-reactive protein (CRP) and myeloperoxidase (MPO) level in the heart of rat model of myocardial infarction.

  2020cites this paper
• Papel da Interleucina 18 e da Proteína Precursora do Trombo na Doença Arterial Coronariana

  2020influential citation
• Biomimetic nanoparticle technology for cardiovascular disease detection and treatment.

  2020cites this paper
• Supplements of an aqueous combination of Justicia adhatoda and Ocimum tenuiflorum boost antioxidative effects and impede hyperlipidemia

  2020cites this paper
• External Self‐Closing Tube to Occlude a Vessel Gradually as a Therapeutic Means of Portosystemic Shunt

  2020cites this paper
• Small Diameter Xenogeneic Extracellular Matrix Scaffolds for Vascular Applications

  2020cites this paper
• Association Between Homocysteine Level and Methylenetetrahydrofolate Reductase Gene Polymorphisms in Type 2 Diabetes Accompanied by Dyslipidemia.

  2020cites this paper
• Role of Interleukin-18 and the Thrombus Precursor Protein in Coronary Artery Disease

  2020cites this paper
• Betanin as a multipath oxidative stress and inflammation modulator: a beetroot pigment with protective effects on cardiovascular disease pathogenesis

  2020cites this paper
• Effect of periodontal treatment in patients with periodontitis and diabetes: systematic review and meta-analysis

  2019cites this paper
• Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis.

  2019cites this paper
• Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke

  2019cites this paper
• Lipoprotein(a) and high-sensitive C-reactive protein as risk factors of coronary heart disease

  2019cites this paper
• From Risk Prediction Models to Risk Assessment Service: A Formulation of Development Paradigm

  2019cites this paper
• The effect of eight weeks of aerobic training and two weeks of detraining on resistin and fibrinogen of elderly male

  2019cites this paper
• Metabolomics in early detection and prognosis of acute coronary syndrome.

  2019cites this paper
• Effects of Bio-Psycho-Socio-Spiritual Factors on Biomarkers of Cardiovascular Inflammation in Elderly Indonesian Muslim

  2019cites this paper
• The Diagnostic Value of Biochemical Cardiac Markers in Acute Myocardial Infarction

  2019cites this paper
• Correlation Between Red Cell Distribution Width and Peripheral Vascular Disease Severity and Complexity

  2019cites this paper
• Long-term exposures to Hypersaline particles associated with increased levels of Homocysteine and white blood cells: A case study among the village inhabitants around the semi-dried Lake Urmia.

  2019cites this paper
• Cinnamaldehyde protects from methylglyoxal-induced vascular damage: Effect on nitric oxide and advanced glycation end products.

  2019cites this paper
• A Study of Measurement of ASCVD Risk Parameters in Patients with Clinical Atherosclerotic Cardiovascular Disease

  2019cites this paper
• What is the impact of traditional risk factors for vascular affection on Behcet’s disease vascular involvement: a retrospective cohort study

  2019cites this paper
• HUMAN TISSUE BIOMAGNETISM ATTRACTING IRON PARTICLES AS PROPOSED MECHANISM ELUCIDATING THE IRON AND ATHEROSCLEROSIS HYPOTHESIS

  2018cites this paper
• DWNN-RLS: regularized least squares method for predicting circRNA-disease associations

  2018cites this paper
• Elevated levels of serum nitrite and nitrate, NOx, are associated with increased total and cardiovascular mortality in an 8‐year follow‐up study

  2018cites this paper
• Contribution of highly active anti-retroviral therapy to the development of non-alcoholic fatty liver disease with concomitant cardiovascular dysfunction in an obese rat model

  2018cites this paper
• 3D Model of Blood Flow for Magnetohydrodynamic Study

  2018cites this paper
• Analysis of Biomarkers (Homocystine/CRP) as Risk Factors for Age-Related Macular Degeneration: A Case Control Study

  2018cites this paper
• Long-Term Survival of Korean Aortic Aneurysm Patients

  2018cites this paper
• Vascular Protection by Ethanol Extract of Morus alba Root Bark: Endothelium-Dependent Relaxation of Rat Aorta and Decrease of Smooth Muscle Cell Migration and Proliferation

  2018cites this paper
• The Role of Inflammation

  2018cites this paper
• The role of oxidative stress as a risk factor for rupture of posterior inferior cerebellar artery aneurysms

  2018cites this paper
• ACCF COMPLEMENTARY MEDICINE EXPERT CONSENSUS DOCUMENT

  2018cites this paper
• Guidance Molecules in Vascular Smooth Muscle

  2018cites this paper
• Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls

  2018cites this paper
• Aging-Induced Biological Changes and Cardiovascular Diseases

  2018cites this paper
• ASSOCIATION OF WAIST-HIP RATIO WITH SEVERITY OF CORONARY ARTERY DISEASE IN PATIENTS UNDERGOING CORONARY ANGIOGRAM FOR ACUTE CORONARY SYNDROME

  2018cites this paper
• Prevention of Atherosclerosis by Berries: The Case of Blueberries.

  2018cites this paper
• Periodontitis and Cardiovascular Risk

  2018cites this paper
• C-reactive Protein Level and Risk of Aging Macula Disorder

  2017cites this paper
• Novel Cardiovascular Risk Markers in Nigerian Cigarette Smokers

  2017cites this paper
• endothelium and angiogenesis in vasculature effect of homocysteine and folic acid

  2017cites this paper
• New-onset severe hypercholesterolemia in a patient with cholestatic liver disease. Should we treat the lipids?

  2017cites this paper
• The Effects of Eicosapentaenoic acid Supplementation in The Patients with Type II Diabetes Mellitus: Study protocol for a randomized controlled trial

  2017cites this paper
• Homocysteine-lowering interventions for preventing cardiovascular events.

  2017cites this paper
• Quantitative and qualitative estimation of atherosclerotic plaque burden in vivo at 7T MRI using Gadospin F in comparison to en face preparation evaluated in ApoE KO mice

  2017cites this paper
• Evaluation of early metabolic and vascular risk in children of parents with early ischaemic heart disease

  2017cites this paper
• Depression and Self-Care of Heart Failure: A Randomized Controlled Trial

  2017cites this paper
• Mendelian randomization: a novel approach for the prediction of adverse drug events and drug repurposing opportunities

  2017cites this paper
• A computational framework to characterize and compare the geometry of coronary networks

  2017cites this paper
• Is Diabetic Skeletal Fragility Associated with Microvascular Complications in Bone?

  2017cites this paper
• In-hospital Outcomes of Acute Myocardial Infarction among old patients

  2017cites this paper
• Molecular analysis of the GSTT1 gene polymorphism in patients with clinical manifestation of atherosclerosis.

  2017influential citation
• Long-term Survival Rates for Patients with Aortic Aneurysm

  2017cites this paper
• A Study on Significance of Non-HDL Cholesterol and Its relation with Cardiovascular Risk in Diabetic Population at GVMCH, Vellore

  2017cites this paper
• Salivary Matrix Metalloproteinase ( MMP-8 ) in Relation to Periodontal Health Status among a Group of Patients with Acquired Coronary Heart Disease

  2017cites this paper
• Association of Adiponectin with Subclinical Atherosclerosis in a Mexican-Mestizo Population.

  2017cites this paper
• Relationship between the severity of coronary artery disease (CAD) and periodontal indices

  2017cites this paper
• Intake of niacin, folate, vitamin B-6, and vitamin B-12 through young adulthood and cognitive function in midlife: the Coronary Artery Risk Development in Young Adults (CARDIA) study.

  2017cites this paper